Page last updated: 2024-11-05

thalidomide and Dermal Sinus

thalidomide has been researched along with Dermal Sinus in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ruffing, L1
Nelham, RL1

Other Studies

2 other studies available for thalidomide and Dermal Sinus

ArticleYear
[The spine in the thalidomide-embryopathy].
    Fortschritte der Medizin, 1980, Mar-20, Volume: 98, Issue:11

    Topics: Ectromelia; Humans; Intervertebral Disc; Sacrum; Scoliosis; Spina Bifida Occulta; Spinal Diseases; S

1980
Carbon fibre reinforced plastic applied to prosthetics and orthotics.
    Journal of biomedical engineering, 1981, Volume: 3, Issue:4

    Topics: Abnormalities, Drug-Induced; Artificial Limbs; Carbon; Carbon Fiber; Humans; Orthotic Devices; Prost

1981